Unapproved neurotoxins abound, dermatologist warns

The approval of the newest botulinum toxin product available in the United States underscores the value of the Food and Drug Administration drug approval process and the importance of using branded products, says Mich?l H. Gold, M.D.

Related Videos
Related Content

The Weekly Roundup: March 20-24

March 24th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Highlights from AAD 2023

March 23rd 2023

Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants

March 23rd 2023

The Weekly Roundup: March 20-24

March 24th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Highlights from AAD 2023

March 23rd 2023

Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants

March 23rd 2023

The Weekly Roundup: March 20-24

March 24th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Highlights from AAD 2023

March 23rd 2023

Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants

March 23rd 2023
© 2023 MJH Life Sciences

All rights reserved.